← Eichor
Study identifier: NCT07563452 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Exercise Intensity and Muscle Recovery in Statin Users

Condition: Statin Adverse Reaction  ·  Sponsor: Raffaele Mazzolari

PhaseNA
Planned participants40
Who can joinAll sexes, 30 Years to 65 Years
Healthy volunteersYes

About this study

This study aims to investigate how different types and intensities of exercise affect muscle recovery in individuals taking statin medications compared to healthy controls. Statins are essential for cardiovascular prevention but are often associated with muscle-related side effects (SAMS), which can be exacerbated by physical activity. The study will compare aerobic cycling (low muscular strain) with resistance training (RT) at increasing intensities (40%, 60%, and 80% of estimated 1-repetition maximum; e1RM). Researchers will measure markers of muscle damage, such as creatine kinase (CK) levels, and subjective recovery needs to determine which exercise modalities and intensities are best tolerated by statin users. The goal is to provide evidence for more individualized and safer exercise recommendations for this population.

This description comes directly from the study's public registry record.

Talk to the study team

Raffaele Mazzolari, Dr.  ·  +393468754234  ·  raffaele.mazzolari@i-med.ac.at

Always discuss trial participation with your own doctor first.

Locations (1)

University of InnsbruckInnsbruck, Tyrol, AustriaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07563452